DHI vs IDXX · P/E 9.6, rev $34.25B vs P/E 40, rev $2.36B
DR Horton Inc (DHI) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
DR Horton Inc (DHI) is a residential construction company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
DHI currently screens at market cap $39.10B and trailing P/E 9.6. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the DHI and IDXX stock pages for the full models.
Not investment advice.